Repros Therapeutics (RPRX) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.31), $0.03 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- KT&G approves KRW 360 billion share buyback and retirement plan
- AutoZone beats profit view but misses on revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
